Flo-Pred is a brand name of prednisolone, approved by the FDA in the following formulation(s):
FLO-PRED (prednisolone acetate - suspension; oral)
Manufacturer: TARO
Approval date: January 17, 2008
Strength(s): EQ 15MG BASE/5ML [RLD]
Has a generic version of Flo-Pred been approved?
No. There is currently no therapeutically equivalent version of Flo-Pred available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Flo-Pred. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Pharmaceutical compositions in semisolid form and a device for administration thereof
Patent 5,881,926
Issued: March 16, 1999
Inventor(s): Ross; Malcolm Stewart Frank
Assignee(s): Taro Pharmaceutical Industries, Ltd.
A pharmaceutical formulation in semisolid form useful for systemic treatment of an illness is disclosed, as well as a device for containing and measuring a unit dose of the formulation comprising a squeezable container having a cap with a spoon attached thereto and closure for resealing the squeezable container after use. A child proof closure useful for the device is also disclosed.Patent expiration dates:
- March 16, 2016✓
- March 16, 2016
Spill resistant pharmaceutical compositions in semi-solid form
Patent 6,071,523
Issued: June 6, 2000
Inventor(s): Mehta; Rakesh & Moros; Dan
Assignee(s): Taro Pharmaceuticals Industries, Ltd.
A spill-resistant pharmaceutical formulation for oral administration from a squeezable container comprises a pharmaceutical agent in a suitable vehicle comprising a liquid base and a thickening agent, the formulation consisting of mutually compatible components and having the following properties: a viscosity within the range of about 7500 to about 12,500 cps using a Brookfield Viscometer with a `C` spindle with Helipath movement at a spindle speed of 20 rpm and 20-25.degree. C., a viscometric yield value of a semi-solid, a spill-resistant consistency permitting the composition to be squeezed by light manual pressure through a channel, to spread in a spoon bowl sufficiently quickly for accurate measurement, and to remain in the spoon bowl without spilling on spoon inversion, tilting at 90 degrees, and vibration, homogeneity such that the components do not separate under conditions of use, and a storage stability such that the foregoing properties are retained for at least two years shelf life. A method for producing a formulation for a spill-resistant pharmaceutical composition comprises combining a per-unit dose effective amount of a pharmaceutical agent with suitable vehicle components comprising a liquid base and a thickening agent, and testing the formulation for acceptance criteria.Patent expiration dates:
- June 3, 2018✓
- June 3, 2018
Pharmaceutical compositions in semisolid form and a device for administration thereof
Patent 6,102,254
Issued: August 15, 2000
Inventor(s): Ross; Malcolm Stewart Frank
Assignee(s): Taro Pharmaceutical Industies Ltd.
A pharmaceutical delivery system for oral administration of a pharmaceutical agent comprises: (a) a squeezable container having an outlet defining a flow channel, (b) a channel closure device adapted to selectively close or open the flow channel; and (c) within the container, at least one dose of a pharmaceutical composition, the composition being a semisolid material that is storage stable, and consists of mutually compatible components, the components comprising (i) an effective amount of an orally active pharmaceutical agent useful for systemic treatment, and (ii) a palatable pharmaceutically acceptable vehicle, comprising a liquid base selected from the group consisting of water, propylene glycol, polyethylene glycol, glycerin, and mixtures thereof, a thickening agent selected from the group consisting of starch, modified starch, sodium carboxymethyl cellulose, microcrystalline cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, other cellulose derivatives, acacia, tragacanth, pectin, gelatin, polyethylene glycol, and water-soluble carboxyvinyl polymers, the pharmaceutical composition having a consistency which allows the composition to be squeezed by manual pressure through the flow channel, whereby in response to pressure on the container when the flow channel is open, a predetermined unit dose of the pharmaceutical composition can be easily squeezed from the container into a receptacle, measured, and administered orally without spilling any of the composition from the container or the receptacle.Patent expiration dates:
- March 11, 2013✓
- March 11, 2013
Spill resistant pharmaceutical compositions in semi-solid form
Patent 6,399,079
Issued: June 4, 2002
Inventor(s): Rakesh; Mehta & Dan; Moros
Assignee(s): Taro Pharmaceutical Industries Ltd.
A spill-resistant pharmaceutical formulation for oral administration from a squeezable container comprises a pharmaceutical agent in a suitable vehicle comprising a liquid base and a thickening agent, the formulation consisting of mutually compatible components and having the following properties: a viscosity within the range of about 7500 to about 12,500 cps using a Brookfield Viscometer with a ‘C’ spindle with Helipath movement at a spindle speed of 10 rpm and 20-25° C., a viscometric yield value of a semi-solid, a spill-resistant consistency permitting the composition to be squeezed by light manual pressure through a channel, to spread in a spoon bowl sufficiently quickly for accurate measurement, and to remain in the spoon bowl without spilling on spoon inversion, tilting at 90 degrees, and vibration, homogeneity such that the components do not separate under conditions of use, and a storage stability such that the foregoing properties are retained for at least two years shelf life. A method for producing a formulation for a spill-resistant pharmaceutical composition comprises combining a per-unit dose effective amount of a pharmaceutical agent with suitable vehicle components comprising a liquid base and a thickening agent, and testing the formulation for acceptance criteria.Patent expiration dates:
- June 3, 2018✓
- June 3, 2018
Spill resistant pharmaceutical system
Patent 6,656,482
Issued: December 2, 2003
Inventor(s): Rakesh; Mehta & Dan; Moros
Assignee(s): Taro Pharmaceutical Industries Ltd.
A spill-resistant pharmaceutical formulation for oral administration from a squeezable container comprises a pharmaceutical agent in a suitable vehicle comprising a liquid base and a thickening agent, the formulation consisting of mutually compatible components and having the following properties: a viscosity within the range of about 7500 to about 12,500 cps using a Brookfield Viscometer with a ‘C’ spindle with Helipath movement at a spindle speed of 10 rpm and 20-25° C., a viscometric yield value of a semi-solid, a spill-resistant consistency permitting the composition to be squeezed by light manual pressure through a channel, to spread in a spoon bowl sufficiently quickly for accurate measurement, and to remain in the spoon bowl without spilling on spoon inversion, tilting at 90 degrees, and vibration, homogeneity such that the components do not separate under conditions of use, and a storage stability such that the foregoing properties are retained for at least two years shelf life. A method for producing a formulation for a spill-resistant pharmaceutical composition comprises combining a per-unit dose effective amount of a pharmaceutical agent with suitable vehicle components comprising a liquid base and a thickening agent, and testing the formulation for acceptance criteria.Patent expiration dates:
- June 3, 2018✓
- June 3, 2018
See also...
- Flo-Pred Consumer Information (Drugs.com)
- Flo-Pred Suspension Consumer Information (Wolters Kluwer)
- Flo-Pred Consumer Information (Cerner Multum)
- Prednisolone Consumer Information (Wolters Kluwer)
- Prednisolone Acetate Suspension Consumer Information (Wolters Kluwer)
- Prednisolone Sodium Phosphate Consumer Information (Wolters Kluwer)
- Prednisolone Sodium Phosphate Liquid Consumer Information (Wolters Kluwer)
- Prednisolone Sodium Phosphate Solution Consumer Information (Wolters Kluwer)
- Prednisolone Syrup Consumer Information (Wolters Kluwer)
- Prednisolone Consumer Information (Cerner Multum)
- Prednisolone AHFS DI Monographs (ASHP)
- Prednisolone Sodium Phosphate AHFS DI Monographs (ASHP)
No comments:
Post a Comment